Lemaitre Vascular (LMAT) FY2014 results: revenue $71 million, up 10.1% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $71 million for fiscal 2014, the year ended 31 December 2014, up 10.1% on the year before. Net income was $4 million, up 22.3%, and diluted earnings per share $0.23. The figures are the company's own, from the 10-K it filed with the SEC on 18 March 2015.
Revenue
$71 million
+10.1% on the year
FY2009FY2014
Operating margin
8.9%
7.0% a year earlier
FY2009FY2014
Net income
$4 million
+22.3% on the year
FY2009FY2014
Diluted EPS
$0.23
+15.0% on the year
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
71.1
64.5
56.7
+10.1%
Cost of revenue
22.7
19.4
15.9
+16.6%
Gross profit
48.4
45.1
40.9
+7.4%
Gross margin
68.1%
69.9%
72.0%
Research and development
4.7
5.2
5.1
-10.9%
Operating income
6.3
4.5
4.2
+40.3%
Operating margin
8.9%
7.0%
7.5%
Interest expense
0.0
0.0
0.0
-58.3%
Pre-tax income
6.3
4.3
4.0
+46.0%
Income tax
2.4
1.1
1.4
+113.6%
Effective tax rate
38.1%
26.0%
35.6%
Net income
3.9
3.2
2.6
+22.3%
Net margin
5.5%
5.0%
4.5%
Diluted EPS
$0.23
$0.20
$0.16
+15.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
5.5
5.4
4.7
+2.3%
Capital expenditure
1.2
2.7
1.2
-57.0%
Free cash flow
4.3
2.7
3.5
+63.4%
Free cash flow margin
6.1%
4.1%
6.2%
Cash from investing
n/a
-6.2
-5.2
Cash from financing
n/a
-1.0
-3.2
Depreciation and amortisation
3.3
2.8
2.2
+19.4%
Share-based compensation
1.3
1.3
1.2
+3.9%
Buybacks
0.2
0.4
2.0
-43.4%
Dividends paid
2.3
1.8
1.5
+25.6%
Dividend per share
$0.14
$0.12
$0.10
+16.7%
Diluted shares, weighted
17m
16m
16m
+7.9%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
68.2
56.6
52.9
+20.6%
Debt
0.0
0.0
0.0
Other liabilities
13.3
13.9
10.2
-4.6%
Total liabilities and equity
81.5
70.5
63.1
+15.6%
Fixed assets
6.9
5.8
4.5
+18.4%
Goodwill
17.3
15.0
13.7
+15.0%
Intangible assets
7.2
6.1
5.2
+16.5%
Cash and equivalents
18.7
14.7
16.4
+27.1%
Receivables
10.8
10.6
9.0
+2.0%
Inventory
16.7
13.3
10.9
+26.1%
Other assets
4.0
5.0
3.2
-19.9%
Total assets
81.5
70.5
63.1
+15.6%
10-K for the year ended 31 December 2014, filed 18 March 2015: the filing.